Penumbra PEN - Options Chain | ADVFN

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NYSE
Penumbra Inc (PEN)
Penumbra Inc (PEN) Options

Penumbra Inc (PEN)

191.68

0.85

(0.45%)

Closed July 15 4:00PM

Delayed by 15 minutes

191.68

0.00

( 0.00% )

Pre Market: 4:09AM

Delayed by 15 minutes

PEN Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
140.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
145.00	44.50	48.90	0.00	46.70	0.00	0.00 %	0	0	-
150.00	39.50	44.00	0.00	41.75	0.00	0.00 %	0	0	-
155.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
160.00	29.50	33.90	94.50	31.70	0.00	0.00 %	0	1	-
165.00	24.50	29.30	0.00	26.90	0.00	0.00 %	0	0	-
170.00	19.50	24.20	0.00	21.85	0.00	0.00 %	0	0	-
175.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
180.00	10.10	13.90	4.10	12.00	0.00	0.00 %	0	5	-
185.00	6.60	9.30	10.00	7.95	0.00	0.00 %	0	203	-
190.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
195.00	0.85	2.60	7.50	1.725	0.00	0.00 %	0	23	-
200.00	0.25	1.25	0.65	0.75	-1.00	-60.61 %	1	89	7/15/2024
210.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
220.00	1.85	1.70	1.85	1.775	0.00	0.00 %	0	6	-
230.00	0.20	1.90	0.20	1.05	0.00	0.00 %	0	126	-
240.00	3.50	4.80	3.50	4.15	0.00	0.00 %	0	801	-
250.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
260.00	1.25	4.80	1.25	3.025	0.00	0.00 %	0	9	-
270.00	0.05	4.80	0.05	2.425	0.00	0.00 %	0	10	-

Professional-Grade Tools, for Individual Investors.

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
140.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
145.00	0.00	4.80	0.00	0.00	0.00	0.00 %	0	0	-
150.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
155.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
160.00	2.60	3.00	2.60	2.80	0.00	0.00 %	0	2	-
165.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
170.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
175.00	0.15	3.70	4.91	1.925	0.00	0.00 %	0	18	-
180.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
185.00	0.15	4.90	1.60	2.525	0.00	0.00 %	0	72	-
190.00	1.00	4.70	6.82	2.85	0.00	0.00 %	0	25	-
195.00	4.60	7.50	14.96	6.05	0.00	0.00 %	0	40	-
200.00	8.60	11.50	8.00	10.05	0.00	0.00 %	0	2	-
210.00	16.90	21.00	29.48	18.95	0.00	0.00 %	0	3	-
220.00	26.20	31.00	33.94	28.60	0.00	0.00 %	0	2	-
230.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
240.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
250.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
260.00	66.60	71.00	27.60	68.80	0.00	0.00 %	0	0	-
270.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CDTConduit Pharmaceuticals Inc	$ 0.49205 (105.02%)	11.51M
WNWMeiwu Technology Company Ltd	$ 1.24 (39.33%)	1.3M
SYRASyra Health Corporation	$ 1.75 (31.09%)	1
VSMEVS Media Holdings Ltd	$ 2.16 (22.73%)	454.43k
PASGPassage Bio Inc	$ 1.08 (17.23%)	12
GRNQGreenpro Capital Corporation	$ 0.9384 (-20.47%)	47.52k
AREBAmerican Rebel Holdings Inc	$ 0.5502 (-18.25%)	61.4k
AMIXAutonomix Medical Inc	$ 1.15 (-16.67%)	238.37k
CYNCYNGN Inc	$ 7.65 (-16.67%)	5.91k
DATSDatChat Inc	$ 1.61 (-14.81%)	70.26k
CDTConduit Pharmaceuticals Inc	$ 0.483 (101.25%)	11.23M
SLNASelina Hospitality PLC	$ 0.0716 (14.38%)	1.51M
WNWMeiwu Technology Company Ltd	$ 1.26 (41.57%)	1.29M
CGBSCrown LNG Holdings Ltd	$ 3.49 (10.79%)	688.32k
MAXNMaxeon Solar Technologies Ltd	$ 0.2215 (-2.42%)	609.65k

@LaughinPaulRyan

@LaughinPaulRyan 4 years ago

... ALL NEWS IS GOOD? ... $PEN

CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

@LaughinPaulRyan

@LaughinPaulRyan 4 years ago

QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
Situation constitutes existential threat to Penumbra’s viability as a public company

@LaughinPaulRyan

@LaughinPaulRyan 4 years ago

Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients

davidsson10

davidsson10 4 years ago

https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link

@LaughinPaulRyan

@LaughinPaulRyan 4 years ago

... ROFLMFAO ... $PEN

Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
CURRENT PRICE

PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020

TREND1

TREND1 9 years ago

IPO INFO

http://www.marketwatch.com/tools/ipo-calendar

TREND1

TREND1 9 years ago

IPO NOW HAS SYMBOL
Penumbra PEN

TREND1

TREND1 9 years ago

IPO should be out soon.
no symbol yet.

Pro Real Estate Investment

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions